Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Ortin Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 8.70 -0.10  | -1.14% -46.79% 16.05 15.25
NSE Price: Dec 06, 15:53 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Dec 06, 15:53 8.70 -0.10 -1.14% 9.25 8.80 7,415 8.65 - 9.25
BSE Dec 06, 2019 9.00 0.08 0.90% 9.00 8.92 1,900 8.61 - 9.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 16,012 P/B: 0.62 NSE Code: ORTINLABSS
52-Week Range: R 8.10 - 17.45 Dividend Yield: 0.00% BSE Code: 539287
TTM EPS: R 0.56 Book Value: R 14.48 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Ortin Laboratories -43.22 -12.96 -7.02 -46.90 -24.30 -6.81 -7.19
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 110.46 38.65 20.10
Net Profit 88.46 15.36 1.53
EPS 88.48 15.36 1.53
Book Value 4.22 2.54 2.70
Average
Operating Margin 4.06 6.68 8.21
Net Margin 0.76 0.79 1.03
Return on Networth 5.21 3.41 3.58
Return on Investment 12.17 10.63 10.89
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -25.02 -30.25 -35.17
Operating Profit -138.50 -142.84 -120.23
Net Profit -461.54 9.96 -153.96
EPS -461.50 9.96 -153.96
TTM
Revenue -7.54 19.90 -3.50
Operating Profit -27.67 -10.39 -26.54
Net Profit 12.29 363.41 -27.81
EPS 12.29 363.47 -27.81
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Ortin Laboratories 15.25 161.88 0.95 0.59 5.21 0.62 16.05
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 08, 2018 G Venkata Ramana  Sell Market 80,061 16.20 12.97
Jan 12, 2016 G Venkata Rama  Sell Market 20,000 28.25 5.65
Nov 30, 2015 A Anantha Laxmi  Sell Market 10,000 33.15 3.32
Nov 30, 2015 G Venkata Rama  Sell Market 40,000 33.15 13.26
Nov 12, 2014 A Ranga Raju  Sell Market 14,044 15.50 2.18
News & Announcements
Contact Information

Company: Ortin Laboratories Ltd.

Address: D. No: 3-4-512/35 (43/4rt), Opp. Barkatpura Park, Barkatpura, Hyderabad, Telangana - 500027 | Phone: 040-27567266 | Fax: 040-66103055

Email: [email protected]

Website: www.ortinlabsindia.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
1.97
Piotroski F-Score
7
Modified C-Score
0
5-Years Price to Earnings
16.05
5-Years Price to Book
0.62
Earnings Yield
EBIT / Enterprise value
10.57%
PEG
Price / Earnings to growth ratio
-3.05
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
Granules India R121.50 -4.44%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
As on Dec 06, 15:59